Tsuneo Imai of Canon U.S.A. Elected to MITA Board of Directors
MELVILLE, N.Y., September 8, 2016 – Canon U.S.A., Inc., a leader in digital imaging solutions, is proud to announce that the Medical Imaging & Technology Alliance (MITA) Board of Directors has elected Tsuneo “Neo” Imai to its board during its July 14 meeting. Effective immediately, Mr. Imai, who serves as vice president and general manager of Business Imaging Healthcare Solutions Group of Canon U.S.A., Inc., as well as president of Virtual Imaging, Inc., a wholly owned subsidiary of Canon U.S.A., will help to bring the board to full strength.
“Neo has demonstrated great leadership, both within Canon and as a member of MITA, and we are thrilled to have him join the board,” said Patrick Hope, executive director, MITA.
“We are thrilled and honored that Mr. Imai has been appointed to the MITA Board of Directors,” said Joe Adachi, chairman and CEO of both Canon U.S.A., Inc. and Virtual Imaging, Inc. “I trust that Mr. Imai will bring his extensive knowledge of digital radiography as well as a spirit of innovation to his new newly elected position.”
“Canon is committed to being a leader and innovator within the imaging industry, and as such we deeply value the Company’s membership in MITA,” said Mr. Imai. “As a member of the board, I’m looking forward to becoming more involved.”
Mr. Imai joined Canon in 1982 before being promoted to manager of Sales Support at Canon U.S.A. in 1993. Over the past 20 years, he has held a variety of management and executive positions, assuming his current positions in 2014. As vice president of the Business Imaging Healthcare Solutions Group, Mr. Imai’s responsibilities span from development and growth of the Healthcare Solutions division, including the establishment of U.S., Canadian and Latin American markets for radiology and ophthalmology imaging products, to sales, marketing, administrative, service, regulatory and quality facets of the Healthcare Solutions Group.
MITA is the collective voice of medical imaging equipment and radiopharmaceutical manufacturers, innovators and product developers. It represents companies whose sales comprise more than 90 percent of the global market for medical imaging technology. These technologies include: magnetic resonance imaging (MRI), medical x-ray equipment, computed tomography (CT) scanners, ultrasound, nuclear imaging, radiopharmaceuticals and imaging information systems. Advancements in medical imaging are transforming healthcare through earlier disease detection, less invasive procedures and more effective treatments. The industry is extremely important to American healthcare and noted for its continual dive for innovation, fast-as-possible production introduction cycles, complex technologies and multifaceted supply chains. Individually and collectively, these attributes result in unique concerns as the industry strives toward the goal of providing patients with the safest, most advanced medical imaging currently available.
About Canon U.S.A., Inc.
Canon U.S.A., Inc., is a leading provider of consumer, business-to-business, and industrial digital imaging solutions to the United States and to Latin America and the Caribbean (excluding Mexico) markets. With approximately $31 billion in global revenue, its parent company, Canon Inc. (NYSE:CAJ), ranks third overall in U.S. patents granted in 2015† and is one of Fortune Magazine's World's Most Admired Companies in 2016. Canon U.S.A. is committed to the highest level of customer satisfaction and loyalty, providing 100 percent U.S.-based consumer service and support for all of the products it distributes. Canon U.S.A. is dedicated to its Kyosei philosophy of social and environmental responsibility. In 2014, the Canon Americas Headquarters secured LEED® Gold certification, a recognition for the design, construction, operations and maintenance of high-performance green buildings. To keep apprised of the latest news from Canon U.S.A., sign up for the Company's RSS news feed by visiting www.usa.canon.com/rss and follow us on Twitter @CanonUSA. For media inquiries, please contact firstname.lastname@example.org.
# # #
† Based on weekly patent counts issued by United States Patent and Trademark Office.